FDA.reportPublic FDA data

SODIUM CAPRYLATE

Substance profile for UNII 9XTM81VK2B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM CAPRYLATE
Structure render from PubChem CID 23664772

Substance Identity#

UNII
9XTM81VK2B
Preferred term
SODIUM CAPRYLATE
Registry number
1984-06-1
EC number
217-850-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C8H15O2.Na
Chemical structure for SODIUM CAPRYLATE
Structure render from PubChem CID 23664772

Chemical And Database Identifiers#

InChIKey
BYKRNSHANADUFY-UHFFFAOYSA-M
SMILES
[Na+].CCCCCCCC([O-])=O
RxCUI
1311123
PubChem
23664772
NCIt
C74148
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound23664772https://pubchem.ncbi.nlm.nih.gov/compound/23664772
PubChem InChIKey SearchBYKRNSHANADUFY-UHFFFAOYSA-Mhttps://pubchem.ncbi.nlm.nih.gov/#query=BYKRNSHANADUFY-UHFFFAOYSA-M
RxNorm1311123https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1311123
NCI ThesaurusC74148https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74148
FDA Substance Registration System9XTM81VK2Bhttps://precision.fda.gov/uniisearch/srs/unii/9XTM81VK2B
European Community number217-850-5https://commonchemistry.cas.org/results?q=217-850-5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SODIUM CAPRYLATEACTIVE INGREDIENT9XTM81VK2BIce Block Liquid2
SODIUM CAPRYLATEINACTIVE INGREDIENT9XTM81VK2BALBURX (ALBUMIN (HUMAN)) SOLUTION [CSL BEHRING AG]6
Sodium CaprylateINACTIVE INGREDIENT9XTM81VK2BHUMAN ALBUMIN GRIFOLS (ALBUMIN (HUMAN)) SOLUTION [GRIFOLS USA, LLC]6
Sodium CaprylateINACTIVE INGREDIENT9XTM81VK2BHUMAN ALBUMIN GRIFOLS (ALBUMIN (HUMAN)) SOLUTION [GRIFOLS USA, LLC]6
Sodium caprylateINACTIVE INGREDIENT9XTM81VK2BALBURX (ALBUMIN (HUMAN)) SOLUTION [CSL BEHRING AG]5
sodium caprylateINACTIVE INGREDIENT9XTM81VK2BMYOBLOC (RIMABOTULINUMTOXINB) INJECTION, SOLUTION [SOLSTICE NEUROSCIENCES, LLC]5
SODIUM CAPRYLATEINACTIVE INGREDIENT9XTM81VK2BFLEXBUMIN (ALBUMIN HUMAN) SOLUTION [BAXTER HEALTHCARE CORPORATION]4
Sodium CaprylateINACTIVE INGREDIENT9XTM81VK2BALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC]3
Sodium CaprylateINACTIVE INGREDIENT9XTM81VK2BALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC]3
Sodium CaprylateINACTIVE INGREDIENT9XTM81VK2BALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC]3
SODIUM CAPRYLATEINACTIVE INGREDIENT9XTM81VK2BFLEXBUMIN (ALBUMIN HUMAN) SOLUTION [BAXTER HEALTHCARE CORPORATION]3
SODIUM CAPRYLATEINACTIVE INGREDIENT9XTM81VK2BBUMINATE (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]2
SODIUM CAPRYLATEINACTIVE INGREDIENT9XTM81VK2BBUMINATE (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]2
SODIUM CAPRYLATEINACTIVE INGREDIENT9XTM81VK2BBUMINATE (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]2
SODIUM CAPRYLATEINACTIVE INGREDIENT9XTM81VK2BFLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]1